Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
Listen to experts report on current publications, posters, and sessions from a recent rheumatology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.